# HYRIMOZ

NDC: 83457-112
Generic name: adalimumab-adaz
Labeler / Manufacturer: Cordavis Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20231215

FDA application: BLA761071

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83457-112"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83457-112
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e303a4a-980b-4f2a-9d03-786928758637